ATOS Message Board Post 18048856 | Atossa Therapeutics Inc.
home / stock / atos / atos message board
Dakotabroadway
(investorshub)
Posted on: Jun/26/2023 01:31:57
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=165798359
$ATOS bears and bulls
News, Short Squeeze, Breakout and More Instantly...
-
SEATTLE, May 15, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”) today announced that the last patient in the Company’s Karisma-Endoxifen clinical trial received their final dose of study medication. Atossa is a clin...
-
2024-05-13 14:15:01 ET H.C. Wainwright analyst issues BUY recommendation for ATOS on May 13, 2024 12:29PM ET. The previous analyst recommendation was Buy. ATOS was trading at $1.4817 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current...
-
Presented data from EVANGELINE study showing 100% disease control rate at 24-weeks Initiated study evaluating (Z)-endoxifen in combination with abemaciclib (VERZENIO®) Ended first quarter 2024 with $84.0 million of cash and cash equivalents and no debt SEATTLE, May ...